L
ONDON--UK company Genostic Pharma has filed to patent a software-based gene-profiling system that can assess a person’s genetic composition and likelihood of contracting certain diseases, said a Reuters report. Genostic Pharma hopes to license the system to pharmaceutical and biotech companies as well as healthcare providers.